Nexien BioPharma (NXEN) Financial Statements

6 Followers

Nexien BioPharma Financial Overview

Nexien BioPharma's market cap is currently $7.08K. The company's EPS TTM is $-0.0029; its P/E ratio is -0.03; Nexien BioPharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -156.00K	$ -283.00K	$ -340.74K	$ -750.10K	$ -2.64M
EBITDA	$ -337.00	$ -392.00	$ -454.00K	$ 0.00	$ -2.64M
Net Income	$ -239.00K	$ -362.00K	$ -626.00K	$ -1.86M	$ -2.67M
Balance Sheet
Cash & Short-Term Investments	$ 4.18K	$ 35.15K	$ 116.90K	$ 18.04K	$ 10.79K
Total Assets	$ 4.18K	$ 43.13K	$ 124.52K	$ 25.54K	$ 22.79K
Total Debt	$ 312.25K	$ 271.49K	$ 221.73K	$ 12.94K	$ 12.00K
Net Debt	$ 308.07K	$ 236.34K	$ 59.83K	$ -5.10K	$ 1.21K
Total Liabilities	$ 365.43K	$ 295.13K	$ 242.12K	$ 39.32K	$ 29.15K
Stockholders' Equity	$ -361.25K	$ -252.01K	$ -117.61K	$ -13.78K	$ -6.37K
Cash Flow
Free Cash Flow	$ -64.36K	$ -81.75K	$ -75.14K	$ -90.75K	$ -147.57K
Operating Cash Flow	$ -64.36K	$ -81.75K	$ -75.14K	$ -90.75K	$ -147.57K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 33.40K	$ 0.00	$ 174.00K	$ 98.00K	$ 12.00K

Currency in USD

Nexien BioPharma Earnings and Revenue History

Income Statement >

Nexien BioPharma Debt to Assets

Balance Sheet >

Nexien BioPharma Cash Flow

Cash Flow >

Nexien BioPharma Forecast EPS vs Actual EPS

Earnings >